« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 3
, Pages 492-494
, March 2008
Aprotinin and Cardiac Surgery
References
- Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg. 1992;54:1031–1036
- . The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353–365
- A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion. 2006;46:327–338
- Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007;297:471–479
- Bleeding in cardiac surgery: the use of aprotinin does not affect survival. J Thorac Cardiovasc Surg. 2008;135:495–502
- Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, Saha SP, Hessel EA 2nd, Haan CK, Royston BD, et al; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, et al. Preioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;83:S27–86.
- Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg. 2006;81:1650–1657
- . Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Circulation. 2007;116(II Suppl):I127–I133
PII: S0022-5223(08)00085-8
doi: 10.1016/j.jtcvs.2007.12.025
© 2008 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 3
, Pages 492-494
, March 2008
